Literature DB >> 19136612

Transcriptional profiling reveals a critical role for tyrosine phosphatase VE-PTP in regulation of VEGFR2 activity and endothelial cell morphogenesis.

Sofie Mellberg1, Anna Dimberg, Fuad Bahram, Makoto Hayashi, Emma Rennel, Adam Ameur, Jakub Orzechowski Westholm, Erik Larsson, Per Lindahl, Michael J Cross, Lena Claesson-Welsh.   

Abstract

To define molecular events accompanying formation of the 3-dimensional (3D) vascular tube, we have characterized gene expression during vascular endothelial growth factor (VEGF)-induced tubular morphogenesis of endothelial cells. Microarray analyses were performed comparing gene induction in growth-arrested, tube-forming endothelial cells harvested from 3D collagen cultures to that in proliferating endothelial cells cultured on fibronectin. Differentially expressed genes were clustered and analyzed for specific endothelial expression through publicly available datasets. We validated the contribution of one of the identified genes, vascular endothelial protein tyrosine phosphatase (VE-PTP), to endothelial morphogenesis. Silencing of VE-PTP expression was accompanied by increased VEGF receptor-2 (VEGFR2) tyrosine phosphorylation and activation of downstream signaling pathways. The increased VEGFR2 activity promoted endothelial cell cycle progression, overcoming the G(0)/G(1) arrest associated with organization into tubular structures in the 3D cultures. Proximity ligation showed close association between VEGFR2 and VE-PTP in resting cells. Activation of VEGFR2 by VEGF led to rapid loss of association, which was resumed with time in parallel with decreased receptor activity. In conclusion, we have identified genes, which may serve critical functions in formation of the vascular tube. One of these, VE-PTP, regulates VEGFR2 activity thereby modulating the VEGF-response during angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19136612     DOI: 10.1096/fj.08-123810

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  59 in total

1.  Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking.

Authors:  Wan Hua Tan; Aleksander S Popel; Feilim Mac Gabhann
Journal:  Cell Signal       Date:  2013-08-29       Impact factor: 4.315

2.  SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers.

Authors:  Sara Zanivan; Federica Maione; Marco Y Hein; Juan Ramon Hernández-Fernaud; Pawel Ostasiewicz; Enrico Giraudo; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2013-08-26       Impact factor: 5.911

3.  Vascular Endothelial Receptor Tyrosine Phosphatase: Identification of Novel Substrates Related to Junctions and a Ternary Complex with EPHB4 and TIE2.

Authors:  Hannes C A Drexler; Matthias Vockel; Christian Polaschegg; Maike Frye; Kevin Peters; Dietmar Vestweber
Journal:  Mol Cell Proteomics       Date:  2019-08-19       Impact factor: 5.911

4.  Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis.

Authors:  Lei Nie; Xiaojia Guo; Leila Esmailzadeh; Jiasheng Zhang; Abolfazl Asadi; Mark Collinge; Xuan Li; Jun-Dae Kim; Melissa Woolls; Suk-Won Jin; Alexandre Dubrac; Anne Eichmann; Michael Simons; Jeffrey R Bender; Mehran M Sadeghi
Journal:  J Clin Invest       Date:  2013-11-01       Impact factor: 14.808

5.  Shear stress-induced redistribution of vascular endothelial-protein-tyrosine phosphatase (VE-PTP) in endothelial cells and its role in cell elongation.

Authors:  Kemala Isnainiasih Mantilidewi; Yoji Murata; Munemasa Mori; Chihiro Otsubo; Takenori Kotani; Shinya Kusakari; Hiroshi Ohnishi; Takashi Matozaki
Journal:  J Biol Chem       Date:  2014-01-22       Impact factor: 5.157

Review 6.  An inside view: VEGF receptor trafficking and signaling.

Authors:  Michael Simons
Journal:  Physiology (Bethesda)       Date:  2012-08

7.  VE-PTP inhibition stabilizes endothelial junctions by activating FGD5.

Authors:  Laura J Braun; Maren Zinnhardt; Matthias Vockel; Hannes C Drexler; Kevin Peters; Dietmar Vestweber
Journal:  EMBO Rep       Date:  2019-05-14       Impact factor: 8.807

8.  Par-4: a new activator of myosin phosphatase.

Authors:  Susanne Vetterkind; Eunhee Lee; Eric Sundberg; Ransom H Poythress; Terence C Tao; Ute Preuss; Kathleen G Morgan
Journal:  Mol Biol Cell       Date:  2010-02-03       Impact factor: 4.138

9.  VEGF stimulates RCAN1.4 expression in endothelial cells via a pathway requiring Ca2+/calcineurin and protein kinase C-delta.

Authors:  Katherine Holmes; Elinor Chapman; Violaine See; Michael J Cross
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

10.  Thioredoxin-interacting protein expression is required for VEGF-mediated angiogenic signal in endothelial cells.

Authors:  Mohammed A Abdelsaid; Suraporn Matragoon; Azza B El-Remessy
Journal:  Antioxid Redox Signal       Date:  2013-07-12       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.